EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma

Tessa Hattenhauer, Rebekka Mispelbaum, Franz-Georg Bauernfeind, Georg Feldmann, Dirk Baumjohann, Johannes Brägelmann, Annkristin Heine, Peter Brossart

Cancer Treatment Reviews · 2026-07 · 148 · 103157

DOI: 10.1016/j.ctrv.2026.103157 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-07. Verfasst von Tessa Hattenhauer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Center for Integrated Oncolog…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Head and Neck Neoplasms, Immune Checkpoint Inhibitors, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyHead and Neck NeoplasmsImmune Checkpoint InhibitorsSquamous Cell Carcinoma of Head and NeckHumansPerioperative CareImmunotherapy

Stichwörter der Autor:innen

Head and neck cancerImmune checkpoint inhibitorNeoadjuvant immunotherapyTranslational immunology

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany. Electronic addre…
  • Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany. Electronic address: dirk.baumjohann@uni-bonn.de.
  • Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany. Electronic address: johannes.braegelmann@uni-bonn.de.
  • Medical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn (UKB), Germany; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany; Clinical Divisio…

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Hattenhauer, T., Mispelbaum, R., Bauernfeind, F. G., Feldmann, G., Baumjohann, D., Brägelmann, J., Heine, A., & Brossart, P. (2026). Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma. Cancer Treatment Reviews, 148, 103157. https://doi.org/10.1016/j.ctrv.2026.103157

Vancouver

Hattenhauer T, Mispelbaum R, Bauernfeind FG, Feldmann G, Baumjohann D, Brägelmann J, et al. Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma. Cancer Treatment Reviews. 2026;148:103157. doi:10.1016/j.ctrv.2026.103157

BibTeX
@article{Hattenhauer2026,
  author = {Hattenhauer, Tessa and Mispelbaum, Rebekka and Bauernfeind, Franz-Georg and Feldmann, Georg and Baumjohann, Dirk and Brägelmann, Johannes and Heine, Annkristin and Brossart, Peter},
  title = {Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma},
  journal = {Cancer Treatment Reviews},
  year = {2026},
  volume = {148},
  pages = {103157},
  doi = {10.1016/j.ctrv.2026.103157}
}
Kostenlos starten →